Header Logo

Connection

LINGEGOWDA SELANERE MANGALA to Pyrimidinones

Back to Details
This is a "connection" page, showing publications LINGEGOWDA SELANERE MANGALA has written about Pyrimidinones.
LINGEGOWDA SELANERE MANGALA
Connection Strength
0.081
Pyrimidinones
  1. MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer. Gynecol Oncol. 2021 10; 163(1):181-190.
    View in: PubMed
    Score: 0.041
  2. Combined VEGFR and MAPK pathway inhibition in angiosarcoma. Sci Rep. 2021 04 30; 11(1):9362.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.